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ABSTRACT 
Malaria morbidity and mortality has remained a major health burden in the developing countries especially in tropical 
Africa. Thus malaria association in pregnancy and its associated complication remains a major health problem to the 
expectant mothers. In this study a total of five hundred and fifty (550) blood specimens were obtained from both pregnant 
and non-pregnant mothers with and without malaria parasitaemia who consented to the study. Selected biochemical and 
haematological parameters were assessed using conventional methods. The result showed that the malaria parasite species 
isolated was plasmodium falcipariumwhich accounted for about 80% of the total population; the age group of 26-35years 
had the highest malaria density for those classified as low (53.7%), average (55.7%) and high (70.4%). This accounted for 
60.7% of the total malaria parasite density. Further analysis of the malaria parasite density on pregnancy according to their 
trimester showed that women on their second trimester of pregnancy had the highest percentage of malaria parasite density 
of 55.7% and this was statistically significant (P>0.05). The result also show that pregnancy with malaria parasitaemia had 
the highest mean ± standard deviation of 20.37± 15.55 while those grouped as having ‘malaria parasitaemia without 
pregnancy’ had the lowest (6.09± 3.76) level of C- reactive protein (CRP). This was also statistically significant (P<0.01).  
 Conclusively, the findings recorded in this study have now shown that malaria parasite infections during pregnancy have 
a significant impact on both the biochemical and haematological indices and the prevalent species of the parasite is 
plasmodium faciparium.  
Keywords: plasmodium faciparium, pregnancy, malaria parasitaemia, morbidity, mortality. 
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RÉSUMÉ                                                                                                                                                                                                  
L'auteurdelamorbidité et de la mortalité du paludismeestresté un important fardeau de la santé dans les pays 
endéveloppement, enparticulierenAfriquetropicale. Ainsi, le paludisme pendant la grossesseetl'associationsa complication 
associéedemeure un problème de santé majeur pour les futures mères. Danscetteétudeun total de cinq cent cinquante (550) 
échantillons de sang ontétéobtenus par les femmes enceintes et non enceintes et mèresd'uneparasitémie sans paludisme 
qui a consenti à l'étude. Certainsparamètreshématologiquesetbiochimiquesontétéévalués à l'aide de 
méthodesconventionnelles. Le résultat a montré que les espèces de parasites du paludisme a étéisoléfalciparium du 
plasmodium qui représentaient environ 80  % de la population totale ; le grouped'âge de 26-35ans avait la plus haute 
densité de paludisme pour ceuxclasséscommefaible (53,7  %), moyenne (55,7  %) et élevé (70,4  %). Celareprésentait 60,7  % 
de l'ensemble du parasite de la densité. Une analyse de la densité des parasites du paludisme sur la grossesseenfonction de 
leurtrimestreontmontré que les femmes sur leurdeuxièmetrimestre de grossesseavaient le pourcentage le plus élevé de 
paludisme la densitéparasitaire de 55,7 % et cen'étaitstatistiquementsignificative (P  > 0,05). 
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Les résultatsmontrentégalement que la grossesse avec le paludisme la parasitémieavaient la plus haute moyenne ± écart-
type de 20,37 ± 15,55 tandis que cellesclasséescommeayant le paludisme la parasitémie sans grossesse' avaient la plus faible 
(6,09 ± 3,76) niveau de la protéineréactive C (CRP). C'étaitaussistatistiquementsignificative (P  < 0,01). 
D'unemanièreconcluante, les résultatsenregistrésdanscetteétudeontmontré que les infections parasites du paludisme 
pendant la grossesseontun impact significatif sur les indices biochimiques et hématologiques et les espècesdominantes du 
parasite Plasmodium estfaciparium. 
Mots clés :grossesse, faciparium plasmodium, le paludisme la parasitémie, morbidité, mortalité. 
INTRODUCTION                                                                 
Malaria, a vector-borne disease is an ancient disease 
probably originating in Africa and is now regarded 
as a life threatening disease with nearly half of the 
world population being vulnerable to the 
infection(1-2). Malaria accounts for an estimated 2-3 
million deaths annually and it is also responsible 
for untold morbidity in approximately 300-500 
million people annually (3). 
Malaria is caused by plasmodium, which is 
transmitted by mosquitoes and the four species of 
plasmodium cause malaria infection in humans. 
These are Plasmodium falciparume, P. vivax, P 
malariae and P. ovale. P. falciparum (4)andis 
responsible for most deaths and most of the severe 
complications (5), including cerebral malaria, 
anemia and renal failure (6).  
Malaria disease generally has severe devastating 
impact on man and it is commonly associated with 
poverty, or a cause of poverty (7), which can lead to 
a major hindrance in economic development. 
Malaria is one of the most common infectious 
diseases creating an enormous public health 
problem. The disease is caused by protozoan 
parasites of the genus Plasmodium. Most species of 
the Plasmodium parasites can infect humans. The 
most serious forms of the disease are caused by 
Plasmodium falciparum while those caused by 
Plasmodium vivax,Plasmodiumovale and Plasmodium 
malariae may cause milder disease in humans that is 
not generally fatal (8). 
Plasmodium infection causes an acute febrile illness 
which is most notable for its periodic fever 
paroxysms occurring at either 48 or 72 hour 
intervals. The severity of the attack depends on the 
Plasmodium species as well as other circumstances 
such as the state of immunity and the general health 
and nutritional status of the infected individual. 
Malaria is a chronic disease which has a tendency to 
relapse or recrudesce over months or even years (9).  
The most common way to obtain malaria is through 
the natural transmission by mosquitoes. Malaria 
can also be transmitted via blood transfusions or 
sharing syringes. Mechanical transmission of 
infected blood will result in a shorter incubation 
period since there will be no liver stage. There is 
also an increased risk of fatality with mechanically-
transmitted P.falciparum. The lack of the liver stage 
infection also precludes relapses in P.vivaxor P.ovale  
infections. Congenital transmission has also been 
documented, but is believed to be relatively rare 
despite the heavy infection of the placenta (10). 
Symptoms of malaria include fever, 
shoveringarthralagia (Joint pains), vomiting, 
anemia caused by haemolysis, hemoglobinuria, 
retinal damage (11) and convulsion. The classic 
symptom of malaria is cyclical occurrence of 
sudden coldness followed by rigor and then fever 
and sweating lasting 4-6hrs, occurring every two 
days in P.vivax and P.ovale infections, while every 
three, for P. malariae (12). P. flaciparum can have 
recurrent fever every 36-48 hrs or a less pronounced 
and almost continuous fever for reasons that are 
poorly understood, but that may be related to high 
intracranial pressure, children with malaria 
frequently exhibit abnormal posturing, a sign 
indicating severe brain damage (13). Malaria has 
been found to cause cognitive impairments, 
especially in children as a result of wide spread of 
anemia during a period of rapid brain 
development. This direct brain and neurologic 
damage results from cerebral malaria to which 
children are more vulnerable (14). 
Severe malaria is almost exclusively caused by 
P.falciparam infection and usually arises 6-14 days 
after infection  consequences of severe malaria 
include coma and death if untreated, young 
children and pregnant women are especially fumble 
splenomegaly, severe headache, cerebral ischemia, 
hepatomegaly hypoglycemia and hemoglobiuria 
from lysed red blood cells leak into the urine. 
Severe malaria can progress extremely rapidly and 
cause death within hours or days (15). 
In most severe cases of the disease fatality rates can 
exceed 20%, even with intensive care and treatment 
(16) in endemic areas because treatment is often less 
satisfactory and the overall fatality rate for all cases 
of malaria can be as high as one in ten over the 
longer term, developmental impairments have been 
documented in children who have suffered 
episodes of severe malaria (17).  Chronic malaria is 
seen in both P.vivax and P.ovale, but not in 
P.falciparum. Here the disease can relapse months or 
years after exposure, due to the presence of latest 
parasites in the liver. Describing a case of malaria as 
cured by observing the disappearance of parasites 
from the blood stream can therefore be deceptive. 
The longest incubation period reported for P.vivax 
infection is 30 years (18). 
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The etiology of malaria in pregnancy is non-
multifactorial of which its causes include poor 
nutrition and infection with other parasites which 
together contribute to increases maternal and 
neonatal morbidity and mortality (19). 
In Nigeria, it’s believed that in the malaria endemic 
area, pregnant women could remain asymptomatic 
despite falciparum infection (20).  It is also clear that 
malaria parasites density differs in instances of 
asymptomatic and clinical malaria while the degree 
of parasitaemia may influence the pathologic and 
biochemical presentations of individuals presenting 
with either of these conditions. 
Unfortunately not much has been done to establish 
the degree of renal involvement or other impaired 
function in malaria association with pregnancy 
cases in Nigeria and Anambra in particular. Hence, 
the present study was designed to assess the 
influence of P. falciparum parasitaemia among pregnant 
mothers and its association on certain biochemical and 
haematological parameters that could be evidence in 
apparently healthy pregnant women. Thus, the 
findings hope to serve as a tool in evidence based 
health education on the need to intensify efforts at 
malaria prevention during pregnancy through 
prompt access to effective treatment, intermittent 
preventive treatment and the consistent use of 
insecticide treated nets. 
MATERIALS AND METHODS                                            
A total of 550 women comprising of 300 pregnant 
women with malaria parasitaemia, 100 non pregnant 
women with malaria parasitaemia and 150 pregnant 
women without malaria parasitaemia who served as 
control, were recruited for this study. The control 
group were selected after data on their health status 
obtained from questionnaire containing relevant 
information responded to indicated healthy status 
before they were screened for the presence of 
Plasmodium falciparum parasitaemia and absence of 
pregnancy by testing negative to a blood pregnancy 
testing. 
Sample Collection                                                                      
Using a 10ml sterile syringe, about 8mls of venous 
blood was collected from each of the subjects and 
4mls of the whole blood transferred into a sterile 
EDTA container while the remaining 4mls was 
dispense into a sterile plain blood bottle and 
allowed to clot. A drop of blood from the EDTA 
bottle was used in making thick and thin blood 
films. The thick films were stained using Giemsa 
stains (21) and examined microscopically using 
100X objective after applying a small drop of 
immersion oil. The intensity of infection was also 
estimated based on the number of parasites counted 
per high power field of the microscope using the 
plus sign system. The remaining venous blood was 
then used in the estimation of some selected 
haematological and biochemical parameters as well 
as C - reactive protein. 
Plasmodium falciparum malaria parasite 
screening: The P. falciparummalaria parasite was 
detected by Microscopic examination of giemsa 
stained thin and thick blood films. The parasitaemia 
was expressed as number of malaria parasites per 
microliter of blood (22). 
Determination of Malaria parasite density                          
Parasite Density: The parasite density is the number 
of parasites counted in each microscopic field. The 
determination of number of parasites per micro-
litre of blood is accomplished by counting the 
number of parasites in relation to a standard 
number of leukocytes per micro-litre (8000) (23).  
Determination of packed cell volume  The packed 
cell volume (PCV) was determined by micro-
heamatocrit centrifugation of EDTA-whole blood 
collected into a capillary tube (24). The volume of 
the packed red cells was measured in a micro-
haematocrit reader and expressed as relative mass 
of packed red cells present in a sample of whole 
blood in terms of percentage (%). 
Creatinine estimation                                                             
The serum creatinine concentration was determined 
using the modified colourimetric method alkaline 
picrate-slot (25) in 1965 using the kit supplied 
Randox (24). 
Urea estimation                                                                        
Serum urea levels were determined using the 
DiacetyiMonoxine (DAM) (26), using the kit 
supplied by Randox (24). 
Estimation of electrolyte levels (Sodium ion and 
potassium ion)                                                                                
Sodium and potassium levels were estimated using 
flame photometry (27). 
Estimation of electrolyte levels (BicarbonateHCO3 
– and Chloride Cl-)The levels of bicarbonate and 
chloride ion were estimated using titrimetric 
method (27). 
Quantitative Estimation of C - reactive protein 
(CRP)                                                                                               
The C- reactive protein (CRP) levels were assayed 
by the methodology for Enzyme Linked Immuno-
sorbent Assay (ELISA) while the Colour was 
developed by Sigma-Fast o-
phenylenediaminedihydrochloride tablets 
(supplied by Sigma, St. Louis, Minneapolis, USA). 
The limit of detection was place at 1µg/ml (CRP). 
Determination of White Blood Cell Count (WBC) 
0.95ml of WBC diluting fluid was put into bijou 
bottle and blood sample was mixed by inverting 
approximately 20 times and 50ml pipette was used 
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to draw blood up into the tip. The content of the 
pipette was then expelled into the diluting fluid and 
the content of the bottle was mixed by inversion. 
The dilution of blood contained in the bottle was 
1:20.  
Statistical Analysis                                                                    
This was performed using Stac-pac Gold package. 
The mean (±SD) was determined for the variables in 
both groups while ANOVA was used to evaluate 
the levels of associations between the variables. The 
levels of significance was considered at p-value 
<0.05 
RESULTS                                                                                     
The results obtained from this study are displayed 
in the tables and figures below. Table I showed that 
the malaria parasite species isolated was 
P.falciparium which accounted for about 80% the 
total population studied.  
 
TABLE 1: PREVALENCE % OF THE DIFFERENT PLASMODIUM SPECIES ISOLATED AMONG PREGNANT WOMEN 
IN IHIALA, ANAMBRA STATE 
 
Species Pregnant women Non-pregnant women Total (%) 
P. falciparum 300 (60%) 100 (20%) 80 
P. ovale 0 (0%) 0 (0%) 0 
P. vivax 0 (0%) 0 (0%) 0 
P. malariae 0 (0%) 0 (0%) 0 
 
TABLE 2: SHOWED THE AGE GROUP (IN YEARS) OF PERCENTAGE (%) PARITY AND PARASITE DENSITY IN 
PREGNANCY WITH MALARIA PARASITAEMIA ONLY 
        AGE (YEARS) Low parasite density N   
(%) Average density N (%) 
High parasite density 
N (%) 
Total N (%) 
15-25 YRS 40   (37.73) 29  (36.70) 25  (21.73) 94    (31.34) 
26 – 35 YRS 57   (53.77) 44  (55.69) 81  (70.43) 182   (60.66) 
36YRS & ABOVE 9     (08.49) 6  (07.59) 9   (07.82) 24 (08.00) 
Total 106   (35.3) 79   (26.3) 115 (38.3) 300 (100.0) 
X2 = 8.507, DF =4, P- value = P > 0.05  
Table 2 showed that the age group of 26-35years 
had the highest malaria parasite density for those 
classified as low (53.7%), Average (55.7%) and high  
(70.4%). This accounted for about 60.7% of the total 
malaria parasite density.  Those above 36 years of 
age had the lowest malaria parasite density of 8.0%.  
 
TABLE 3: SHOWED THE PERCENTAGE (%) PARITY AND PARASITE DENSITY IN THE DIFFERENT TRIMESTER OF 
PREGNANCY WITH MALARIA PARASITAEMIA 
TRIMESTER Low parasite density 
N (%) 
Average parasite 
density N (%) 
High parasite density 
N (%) 
Total N (%) 
First trimester 20 (26.41) 22 (27.84) 24 (12.5) 74 (24.67) 
Second trimester 53 (50.0) 38 (48.00) 76 (3.9) 167 (65.67) 
Third trimester 25 (23.58) 19 (24.05) 15 (20) 59 (19.66) 
Total 106 (35.3) 79 (26.3) 115 (38.3) 300 (100) 
     
X2 = 8.959, DF =4, P > 0.05  
 
Further analysis of the malaria parasite density on 
pregnancy according to their trimester showed that 
women on their second trimester of pregnancy had the 
highest  percentage of malaria parasite density of 55.7%.  
whereas those on their third trimester had the lowest 









TABLE 4: SHOWED THE MEAN + S.D OF C REACTIVE PROTEIN (CRP) FOR PREGNANCY WITH AND WITHOUT 
MALARIA PARASITE AND CONTROL GROUP 
Pregnant women Non Pregnant Women     
Parameter Without MP (n=150) With MP 
(n=300) 
With MP (n=100) p-value 








Table 4 showed that pregnancy with malaria 
parastaemia had the highest mean+ standard 
deviation of CRP (20.37+ 15.55) while those groups  
as malaria parasitaemia without pregnancy had the 
lowest (6.09+ 3.76) level of CRP. This was found to 
be statistically significant (P<0.01). 
TABLE 5: SHOWED THE MEAN + S.D OF C REACTIVE PROTEIN (CRP) FOR PREGNANCY WITH AND WITHOUT 
MALARIA PARASITE ACCORDING TO TRIMESTER 
 
Subjects 
CRP at Different Trimesters of Pregnancy  





































Further analysis on the CRP levels according to 
trimester should that the third trimester of the 
pregnancy with malaria parasitaemia group had the 
highest mean (24.82 + 16.94) for CRP. While those 
group under second trimester had the lowest mean 
(18.44 + 10.46) for CRP. Those on their third  
trimester of pregnancy for the pregnancy group 
without malaria parasitaemia had the lowest mean 
(19.93 + 6.48). of CRP. This was statistical of 
pregnancy significant (P<0.01) as shown in table 5 
above.   
TABLE 6:SHOWED THE MEAN + SD OF ELECTROLYTE, UREA AND CREATININE IN PREGNANCY WITH AND 
WITHOUT MALARIA PARASITE AND THEIR CONTROL GROUP (MALARIA PARASITE WITHOUT 
PREGNANCY). 
 
Parameter Pregnant Women Non Pregnant women P value 













































Urea (mg/dl) 20.66+ 6.12 30.08+4.62 15. 39+ 7.70 p<0.01 
Creatinine 













Table 6 showed that potassium, (5.38+1.35), 
chloride (105.25+9.28) and bicarbonate (26.13+ 1.55) 
statically increase (P<0.05) for the pregnant women 
without malaria parasitaemia when compared to the 
non-pregnant women with malaria parasitaemia 
(potassium ion (4.18+0.64) chloride ion (89.66+ 8.20) 
and bicarbonate (22.10+9.74). Similarly, urea (20.66+ 
6.12) and creatinine (2.75+ 1.24), decrease significant 
(p<0.05) among the pregnant women with malaria 
parasitaemia when compare to those pregnant 
women without malaria parasitaemia (urea=30.08+ 
4.62 and creatinine =3.23+ 1.37)  
TABLE 7: SHOWED THE MEAN + S.D OF ELECTROLYTE, UREA AND CREATININE PARAMETERS IN PREGNANCY 
WITH OR WITHOUT MALARIA PARASITAEMIA 
 
 Pregnant Women P value 
 
Table 7 showed that in 
pregnancy, sodium ion 
increases (142.75 + 7.26) 
with malaria parasitaemia 
while potassium ion (4.55 + 
4.11) Bicarbonate ion (24.76 
+ 4.30), choride ion (101.51+ 
8.16), urea (20.66+ 6.12) and 
creatinine (2.75 + 1.24) 
decreases respectively with 
malaria parasitaemia This 











































































TABLE 8: SHOWED THE MEAN + SD OF ALKALINE PHOSPHATASE, AMINO-TRANSAMINASES & BILIRUBIN 
LEVELS IN PREGNANCY WITH AND WITHOUT MALARIA PARASITE AND THEIR CONTROL GROUP. 
Parameter 
 
Pregnant Women Non- Pregnant  
P value 
 
with MP                  without MP 
(n=300)                    (n=150) 
women with MP 
(n=100)               
Alkaline Phosphate 


































































Table 8 showed a statistically significant increase 
(P<0.05) in the pregnancy group without M.P for 
Alkaline phosphate (66.88+ 6.29). Alanine 
aminotrasarminase (14.75+ 2.34), Asparate 
aminotransminase when campare to their 
pregnancy with M.P (Alkaline phosphate, 42.96+ 
8.12 Alamineaminotransminase, 8.27+ 3.27 and  
Asparate aminotransaminase, 10.27+ 3.70) and their 
non-pregnant group with M.P (Alkaline 
phosphatase, 15.6+6.09, Alamine 
aminotransaruinase 7.79+4.32 and Asparate 
aminotransaminase 7.79+ 4.32 and Asparate amino 
transaminase 8.19+ 4 
 
TABLE 9: SHOWED THE MEAN + SD OF ALKALINE PHOSPHATASE, AMINO-TRANSAMINASES & BILIRUBIN 





























































Unconjugate Bilirubin (mg/dl)    
 




Table 9 showed a statistically significant decrease 
(P<0.05) in akaline phosphate (42.96+ 8.12) in 
pregnant women with malaria parasite when 
compare to those without malaria parasitaemia 
(66.88+ 6.29). While total Bilirubin  
showed a significant (P<0.05) increase in those with 
malaria parasitaemia (3.77+ 1.01) when compared to 
those without malaria parasitaemia (2.31+ 2.60 
TABLE 10: SHOWED THE MEAN + S.D. % PCV, HAEMOGLOBIN & TOTAL WHITE BLOOD CELL COUNT LEVELS 













(n=300)   

































P<0.01   
 
 
Table 10 showed a significant increase (P<0.01) in 
the % PCV for non- pregnancy women with malaria 
parasite (38.06+ 3.76), when compare to the 
pregnant women with malaria parasite (37.13 
+2..17) and those without malaria parasite (34.22+ 
4.22) The Hb (14.08+ 11.40) and total WBC /6937.5+ 
1988.49 of pregnant women with malaria parasite 
was increase when compare to both pregnant 
women without malaria parasite (Hb=11.38+ 1.20 
WBC-total =5701.3+2478.04) and non-pregnant 
women with malaria parasite (Hb=12.5+1.08 WBC-
total = 3958.30+ 2049.00 
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TABLE 11: SHOWED THE MEAN + S.D. %PCV, HAEMOGLOBIN & TOTAL WHITE BLOOD CELL COUNT LEVELS 
FOR PREGNANCY WITH AND WITHOUT MALARIA PARASITE 
 
 
  Parameter 
Pregnant Women     
 



























P<0.01   
 
 
Table 11 showed that % PCV (34.22+ 4.22), Hb 
(11.38+1.20) and total WBC (5701.3+2478.04) of 
pregnant women without malaria parasite  
 
significantly decrease (P<0.05) when compared to 
their pregnant women with malaria parasite (% 
PCV (37. 13+ 2.17); Hb (14.08+ 11.40) and total WBC 
(6937.50+ 1988.49) 
 
TABLE 12: THE MEAN + S.D. % PCV, HAEMOGLOBIN & TOTAL WHITE BLOOD CELL COUNT LEVELS VERSUS 
PARITY FOR PREGNANCY WITH MALARIA PARASITE 
 
TABLE 13: SHOWED THE PERCENTAGE (%) PARITY AND PARASITE DENSITY IN PREGNANCY WITH MALARIA     
PARASITAEMIA 










HIGH DENSITY  TOTAL  
  N           (%)  N         (%)  N              (%)  N          (%) 
0  31      (29.25)  12       (15.19)  37         (32.17)  80     (26.67) 
1  29      (27.35)  37       (46.84)     32         (27.82)  98     (32.67) 
  
      
 
2  22      (20.75)  18       (22.78)  23         (20.00)  63    (21.00) 
         
3  17    (16.04)   9        (11.39)  12         (10.43)  38     (12.67) 
4      0       0.0)  3        (03.80)  5          (04.35)  8        (2.67) 
5  7     (06.60)  0        (0.0)  3          (02.61)  10      (3.33) 
6  0      (0.0)  0        (0 .0)  3          (02.61)  3       (1.00) 
  106     (35.3) 79      (26.3)  115          (38.3)         300     (100) 






















         
MEAN±SD   MEAN ± SD   MEAN ±SD  MEAN± SD             (MEAN ±SD)  MEAN± SD             MEAN± SD             P- VALUE 
          
PCV 34.42±3.50 34.1±5.13 34.60±1.93  33.39±5.7 38.1±2.59 31.50±4 37.00±0.00 P<0.05 
          
HB 11.40±1.16 11.33±1.71 11.52±0.63  11.12±1.90 12.70±0.82 10.49±0.82 12.30±0.00 P<0.05 
          
WBC 57.75±38.6 
 
59.63±21 56.19±15.84  52.80±12.81 57.00±10.51 62.00±19.33 68.00±0.00 P> 0.05 
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Table 13: Showed that women who were on their 
first and second pregnancies had the highest 
percentage of malaria parasite density of 32.7% and 
26.7%. While those who had above four pregnancies 
had the lowest amount of malaria parasite density 
of 2.7% for four (4), 3.3% for five (5) and 1.0% for 
six(6) pregnancies outcome.  
DISCUSSION                          
Prevalence of malaria infection                                     
Malaria infection during pregnancy is a major 
public health problem in tropical and sub-tropical 
regions around the globe. The result in this study 
confirms that plasmodium falciparum species of is 
the prevalent specie of plasmodium that was 
isolated among pregnant women with malaria 
parasitaemia in Ihiala, Anambra State, This specie 
accounted for a prevalence rate of 80% a shown on 
table 1. This finding can be compared to the report 
ofIsmail(28) who reported that over 90% of the 
global malaria burden occurs in the Southern parts 
of Africa. Although, P.faciparuim has been reported 
as the predominate species isolated among 
pregnant women in the tropics (29)but the 
presentation of asymptomatic malaria parasitaemia 
is different from that of severe or clinical malaria 
parasitaemia in during pregnancy. This may be due 
to the differences in malaria parasite density in the 
blood of the infected individual (30).had a higher 
percentage of parasite density (26.7% and 32.7%) 
when compared to those with more episodes of 
pregnancies (i.e. above four pregnancies outcome) 
The high parasite density reported may be due to 
immune suppression among those individuals on 
their first and second pregnancies which is a 
consequences of the effect of the plasmodium 
faciparuim infection among these individual and 
tends to improve as the pregnancies out-come 
exceed four (4), times. Thus, there is an acquired 
immunity against malaria (table 2). This can be 
compared to the report ofDicko (31), who observed 
that the severity of malaria infection depends 
largely on the degree of malaria parasitemia, and 
pregnancy may increases the risk of malaria 
infection (32).  
Similar analysis on the severity of high parasite 
density among the age group of pregnant women 
revealed that the number of the 2nd trimester 
pregnant women who visited the antenatal clinic 
was more than those in their 1st and 3rd trimester 
possibly because these groups of patient felt there 
was no clinical need. There was also significantly 
(P<0.01) increase in the parasite density among 
those with maternal age of 26 to 35 yrs. This finding 
can be compared to that of Olshake(33) who 
reported a lower parasite density among maternal 
age less than 20yrs.   
Inflammatory proteins                                                   
C-reactive protein (CRP) is a protein found in the 
blood and whose levels increases in response to 
inflammation (34). The findings from this study 
confirms that during the episode of pregnancy there 
was an elevated CRP (14.17+ 6.09) as seen among 
pregnant women without malaria parasitaemia and 
becomes severe when there is malaria parastaemia 
(20.37+ 15.55) as shown in table 4. This elevated 
CRP levels were observed among the third 
trimester of pregnancy for those with malaria 
parasitaemia (table 5). This finding can be compared 
to the work done by (35) who have reported higher 
values for CRP during late pregnancy.  
Biochemical Indices in Pregnancy with malaria 
parasitaemia                                                                      
Alterations in biochemical parameters have been 
investigated and reported by several authors in 
malaria infections (1, 36). This has helped to 
intensify care for this group of patients and thus 
prevent death that may results from malaria 
complications. The result obtained from this study 
shows the impact of malaria and pregnancy on 
biochemical parameters, in Ihiala, Anambra State. 
Data presented in this study shows that urea and 
creatinine was significantly (P<0.05) decreased in 
pregnancy with malaria partasiteamia when 
compared with those without malaria parasitaemia. 
The concurrent decrease in the urea and creatinine 
reveals that there is a functional glomerular 
fitteration rate. This finding can be compared to the 
work done by Etimet al. (37) who reported an 
elevated urea and creatinine level.  
In this study, there was a significant (P<0.05) 
increase in sodium ion and a significant (P<0.05) 
increase in sodium ion and a significant (P<0.05) 
decrease in Bicarbonate ion, and chloride ion. These 
changes may have resulted from the continuous 
haemolytic effect of the plasmodium falciparium 
parasite on the red cells which in-form will affect 
the ionic concentration of the whole blood uncosity. 
Furthermore, this study also reveals that there is an 
alteration in the luier enzymes of pregnancy with 
malaria parasitaemia (table 9). There was a 
significant decrease infection. This can be compared 
to the work done by Adeosun et al.(38) who 
reported elevated or hyperbilirusinaemia in malaria 
which is a consequence of hamolysis and concluded 
that a severe infection can reflect luier damage. 
Thus, this study reveals a mild elevation in the 
bilirubin level of pregnant women with malaria 
parasitaemia.            
Haematological indices in pregnancy                                
The impacts of malaria on haematological 
parameters during pregnancy have been with 
malaria parastaemia poorly studied in Anambra 
State. In this study the impact of malaria on 
haematological parameters, had a significant 
increase (p<0.01) in the %age packed cell volume of 
the multigravidae with an average mean value of 
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31.5% with a corresponding mean hemoglobin level 
of 10.5g/dl These findings can be compared to the 
work done by Onyenekwe et al. (39) who reported a 
low %age for PCV in the primigraviae. However in 
areas of stable transmission like Anambra State, 
most adult women have developed enough 
immunity that during pregnancy, P.falciarum 
infection does not usually result in fever or other 
clinical symptoms. It is also clear that malaria 
parasites density fifers in instances of asymptomatic 
and clinical malaria (Onyenekweet al (39).The 
degree of parasite density and the parasite density 
threshold could explain the reason for the 
difference. Similarly there was also no significant 
difference (p>0.05) in the total white cell count 
(wbc). Thus anaemia as a presenting feature is more 
common in partially immune multigravida, living 
in hyper-endemic areas having malaria during 
pregnancy (40) 
The pattern of % PCV among the study group was 
also observed. In the P.C.V. coded as low, and 
normal, the highest percentage of the low P.C.V 
was recorded in the mulliparous 44 (30.8%) and 
primigravidae 43 (30.1 %). Also the greater 
percentage of low pcv was recorded among those 
on 2nd trimester of pregnancy. This may be as the 
result of haemolysis causes by malaria parasites. 
This finding can be compared to the work done by 
(41) that malaria causes neutropemia and anaemia. 
CONCLUSION                                                                           
The findings recorded in this study have now 
shown that malaria parasite infection during 
pregnancy has a significant impact on both the 
biochemical and haematological indices. The 
prevalent species of the parasite is plasmodium 
faciparium and the degree of parasitaemia may result 
in inflammatory changes which are observed. Thus, 
the following contribution to knowledge was 
made:1. Prevalence rate of P.faciparium infection 
80%.2. The maternal age of 26-35 years old had the 
highest degree of parasite density.3. There was 
significant changes in the liver enzymes especially, 
Alkaline phosphatase and the amino transaminase 
of pregnant women with malaria parasitaemia.4. 
There was a significant decrease in the urea and 
creatinie level of pregnant women with malaria 
parasitaemia. 5. There was a significant increase in 
the CRP, which serve as a pointer to the underlying 
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